Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CryoPort, Inc. stock logo
CYRX
CryoPort
$15.81
-0.3%		$15.71
$7.61
▼
$17.20
$803.29M1.89551,651 shs314,164 shs
Evotec AG stock logo
EVO
Evotec
$1.86
-2.1%		$2.15
$1.80
▼
$4.27
$676.06M1.9243,098 shs121,906 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.69
+1.7%		$0.79
$0.63
▼
$1.72
$264.56M1.371.59 million shs1.76 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$127.78
-0.6%		$107.63
$58.83
▼
$132.70
$719.24M0.97169,661 shs100,558 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CryoPort, Inc. stock logo
CYRX
CryoPort
+0.51%-4.28%+4.20%+1.02%+86.59%
Evotec AG stock logo
EVO
Evotec
0.00%-3.55%-2.56%-32.14%-44.77%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
+0.09%+3.20%-17.87%-41.40%-47.76%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
-1.62%-0.09%+27.08%+23.72%+109.37%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CryoPort, Inc. stock logo
CYRX
CryoPort
$15.81
-0.3%		$15.71
$7.61
▼
$17.20
$803.29M1.89551,651 shs314,164 shs
Evotec AG stock logo
EVO
Evotec
$1.86
-2.1%		$2.15
$1.80
▼
$4.27
$676.06M1.9243,098 shs121,906 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.69
+1.7%		$0.79
$0.63
▼
$1.72
$264.56M1.371.59 million shs1.76 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$127.78
-0.6%		$107.63
$58.83
▼
$132.70
$719.24M0.97169,661 shs100,558 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CryoPort, Inc. stock logo
CYRX
CryoPort
+0.51%-4.28%+4.20%+1.02%+86.59%
Evotec AG stock logo
EVO
Evotec
0.00%-3.55%-2.56%-32.14%-44.77%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
+0.09%+3.20%-17.87%-41.40%-47.76%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
-1.62%-0.09%+27.08%+23.72%+109.37%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CryoPort, Inc. stock logo
CYRX
CryoPort
2.67
Moderate Buy$18.0013.85% Upside
Evotec AG stock logo
EVO
Evotec
2.00
Hold$3.0061.29% Upside
Standard BioTools Inc. stock logo
LAB
Standard BioTools
1.67
Reduce$1.3596.94% Upside
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
2.00
Hold$110.00-13.91% Downside

Current Analyst Ratings Breakdown

Latest LAB, CYRX, MLAB, and EVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
Evotec AG stock logo
EVO
Evotec
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/17/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D)
8/14/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$94.00 ➝ $110.00
8/11/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Hold (C-)
8/7/2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$12.00 ➝ $16.00
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$21.00
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $19.00
8/3/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
7/24/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $25.00
7/21/2026
Evotec AG stock logo
EVO
Evotec
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CryoPort, Inc. stock logo
CYRX
CryoPort
$176.18M4.55N/AN/A$8.77 per share1.80
Evotec AG stock logo
EVO
Evotec
$891.97M0.74N/AN/A$2.17 per share0.86
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$85.33M3.15N/AN/A$1.38 per share0.50
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$249.13M2.87$11.70 per share10.92$33.73 per share3.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CryoPort, Inc. stock logo
CYRX
CryoPort
$78.30M-$0.90N/AN/AN/A-20.05%-7.20%-4.30%11/3/2026 (Estimated)
Evotec AG stock logo
EVO
Evotec
-$117.12MN/AN/A46.50N/A-26.20%-24.93%-11.35%11/5/2026 (Estimated)
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$74.90M$0.22N/AN/AN/A100.36%-7.57%-6.14%11/3/2026 (Estimated)
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$6.71M$0.84152.12N/AN/A1.92%22.72%9.82%11/5/2026 (Estimated)

Latest LAB, CYRX, MLAB, and EVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q1 2027
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
N/A$2.68N/A$0.49N/A$60.14 million
8/6/2026Q2 2026
CryoPort, Inc. stock logo
CYRX
CryoPort
-$0.1933-$0.20-$0.0067-$0.20$48.18 million$48.97 million
8/5/2026Q2 2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$0.0128-$0.07-$0.0573-$0.07$20.80 million$20.10 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CryoPort, Inc. stock logo
CYRX
CryoPort
N/AN/AN/AN/AN/A
Evotec AG stock logo
EVO
Evotec
N/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$0.640.50%N/A76.19%N/A

Latest LAB, CYRX, MLAB, and EVO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/6/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
quarterly$0.160.5%8/31/20268/31/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CryoPort, Inc. stock logo
CYRX
CryoPort
N/A
2.08
1.98
Evotec AG stock logo
EVO
Evotec
0.62
2.33
2.21
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
9.10
8.80
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
0.73
1.79
1.32

Institutional Ownership

CompanyInstitutional Ownership
CryoPort, Inc. stock logo
CYRX
CryoPort
92.90%
Evotec AG stock logo
EVO
Evotec
5.81%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
90.60%

Insider Ownership

CompanyInsider Ownership
CryoPort, Inc. stock logo
CYRX
CryoPort
9.50%
Evotec AG stock logo
EVO
Evotec
1.00%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
26.81%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
CryoPort, Inc. stock logo
CYRX
CryoPort
1,18650.65 million45.84 millionOptionable
Evotec AG stock logo
EVO
Evotec
4,553355.82 million352.26 millionNot Optionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620392.58 million287.33 millionOptionable
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
6805.60 million5.44 millionNot Optionable

Recent News About These Companies

Mesa Laboratories Inc (MLAB) Shares Surge 4.1% -- What GF Score of 75 Tells Investors
September 2 at 10:00 PM  |  gurufocus.comhttps://www.gurufocus.com/news/9065149/mesa-laboratories-inc-mlab-shares-surge-41-what-gf-score-of-75-tells-investors
Mesa Laboratories (NASDAQ:MLAB) Sets New 12-Month High - Here's Why
September 2 at 4:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30999322
Mesa Laboratories (NASDAQ:MLAB) Sets New 52-Week High - Here's Why
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-mesa-laboratories-nasdaq-mlab-sets-new-52-week-high-heres-why-2026-08-31/
Globeflex Capital L P Takes Position in Mesa Laboratories, Inc. $MLAB
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-globeflex-capital-l-p-takes-position-in-mesa-laboratories-inc-mlab-2026-08-25/
Mesa Laboratories (NASDAQ:MLAB) Reaches New 12-Month High - What's Next?
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-mesa-laboratories-nasdaq-mlab-reaches-new-12-month-high-whats-next-2026-08-25/
Ranger Investment Management L.P. Makes New $17.32 Million Investment in Mesa Laboratories, Inc. $MLAB
August 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-ranger-investment-management-lp-makes-new-1732-million-investment-in-mesa-laboratories-inc-mlab-2026-08-24/
Mesa Laboratories, Inc.
August 22, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/mlab-mesa-laboratories-inc/vitals
Mesa Laboratories (NASDAQ:MLAB) Reaches New 52-Week High - What's Next?
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-reaches-new-52-week-high-whats-next-2026-08-19/
Mesa Laboratories (NASDAQ:MLAB) Director R Tony Tripeny Buys 900 Shares
August 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mlab-insider-buying-and-selling-2026-08-18/
R Tony Tripeny Acquires 900 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/r-tony-tripeny-acquires-900-shares-of-mesa-laboratories-nasdaqmlab-stock-2026-08-17/
Siddhartha Kadia Buys 7,093 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/siddhartha-kadia-buys-7093-shares-of-mesa-laboratories-nasdaqmlab-stock-2026-08-17/
Insider Selling: Mesa Laboratories (NASDAQ:MLAB) Director Sells $800,090.40 in Stock
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-mesa-laboratories-nasdaqmlab-director-sells-80009040-in-stock-2026-08-17/
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Mesa Laboratories, Inc. $MLAB
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-diamond-hill-capital-management-llc-investment-advisor-makes-new-investment-in-mesa-laboratories-inc-mlab-2026-08-17/
Mesa Laboratories (NASDAQ:MLAB) Rating Lowered to Buy at Wall Street Zen
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-rating-lowered-to-buy-at-wall-street-zen-2026-08-15/
Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 6% - Time to Sell?
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-stock-price-down-6-time-to-sell-2026-08-14/
Mesa Laboratories (NASDAQ:MLAB) Given New $110.00 Price Target at Wells Fargo & Company
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-given-new-11000-price-target-at-wells-fargo-company-2026-08-14/
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High - Here's Why
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-hits-new-12-month-high-heres-why-2026-08-13/
Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wasatch-advisors-lp-increases-position-in-mesa-laboratories-inc-mlab-2026-08-13/
Mesa Laboratories targets 1.5–1.75x net leverage by fiscal 2027 exit while resetting Gyrolab launch to fiscal 2028
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4630401-mesa-laboratories-targets-1_5-1_75x-net-leverage-by-fiscal-2027-exit-while-resetting-gyrolab
Mesa Laboratories (NASDAQ:MLAB) Sees Large Volume Increase - What's Next?
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-sees-large-volume-increase-whats-next-2026-08-11/
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
August 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934313-mesa-laboratories-inc-mlab-q1-2027-earnings-call-transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Rocket Lab logo displayed on a sign with a rocket on a launch pad at sunset in the background.
Rocket Lab’s Record Quarter Still Left Investors Waiting on Neutron
By Ryan Hasson | August 11, 2026
Rocket Lab logo beside a rocket launching from its pad amid smoke and flames against a dark sky.
Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
By Ryan Hasson | August 23, 2026
JFrog logo displayed on a glass panel surrounded by green liquid splashes in a server room setting.
JFrog’s AI Opportunity Could Fuel a Big Leap in Share Price
By Thomas Hughes | August 17, 2026
Astera Labs logo displayed on a server component mounted in a data center rack with illuminated network cables.
Astera Labs' Post-Earnings Pullback May Be Last Chance to Buy Below $360
By Thomas Hughes | August 6, 2026
Illuminated Voyager logo on a screen with a satellite orbiting Earth in the background.
Voyager Technologies: Space Force Deal Fuels Growth Despite Heavy Cash Burn
By Jeffrey Neal Johnson | August 13, 2026
CryoPort stock logo

CryoPort NASDAQ:CYRX

$15.81 -0.05 (-0.32%)
As of 04:00 PM Eastern

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Evotec stock logo

Evotec NASDAQ:EVO

$1.86 -0.04 (-2.11%)
As of 04:00 PM Eastern

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$0.69 +0.01 (+1.72%)
As of 04:00 PM Eastern

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Mesa Laboratories stock logo

Mesa Laboratories NASDAQ:MLAB

$127.78 -0.75 (-0.58%)
As of 04:00 PM Eastern

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas